Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05919238
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2023-05-19
Brief Title:
Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Sponsor:
Impact Biotech Ltd
Organization:
Impact Biotech Ltd
Organization Data
Organization:
Impact Biotech Ltd
Class:
INDUSTRY
Study ID:
CLIN2301 PNCM101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Impact Biotech Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None